Share on StockTwits

Investment analysts at Canaccord Genuity initiated coverage on shares of Trupanion (NASDAQ:TRUP) in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $13.00 price target on the stock. Canaccord Genuity’s price target would suggest a potential upside of 27.33% from the company’s current price.

A number of other analysts have also recently weighed in on TRUP. Analysts at Barclays initiated coverage on shares of Trupanion in a research note on Tuesday. They set an “overweight” rating and a $15.00 price target on the stock. Separately, analysts at Stifel Nicolaus initiated coverage on shares of Trupanion in a research note on Tuesday. They set a “buy” rating and a $18.00 price target on the stock. Finally, analysts at RBC Capital initiated coverage on shares of Trupanion in a research note on Tuesday. They set an “outperform” rating and a $14.00 price target on the stock.

Shares of Trupanion (NASDAQ:TRUP) opened at 10.14 on Tuesday. Trupanion has a 52 week low of $9.31 and a 52 week high of $11.95. The stock’s 50-day moving average is $10.40 and its 200-day moving average is $10.40. The company’s market cap is $269.3 million.

Trupanion, Inc, is a direct-to-consumer monthly subscription service providing a medical insurance plan for cats and dogs throughout the United States, Canada and Puerto Rico.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.